[Treatment of refractory primary depression].
Refractory depressions are depressions that respond insufficiently to treatment with the standard antidepressants, given long enough and in adequate dosage. If tricyclic antidepressants or selective serotonin reuptake inhibitors are insufficiently efficacious, an augmentation strategy may be applied. Drugs with a reinforcing effect on antidepressant medication are lithium and possibly liothyronine (triiodothyronine). If the results are nil or insufficient, administration of MAO inhibitors may be resorted to. Finally, electroconvulsive treatment may be administered to patients with a vital depression. If in depression there are indications of personality disorders and/or stressful life situations, treatment should comprise not only antidepressants but also psychological intervention and psychosocial measures.
van Praag
H M
HM
Vakgroep Psychiatrie en Neuropsychologie, Universiteit Maastricht.
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003863:Depression / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D011613:Psychotherapy; D013963:Thyroid Hormones / Q000627:therapeutic use; D014284:Triiodothyronine / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors; D013963:Thyroid Hormones; D014284:Triiodothyronine; D008094:Lithium